Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

China Aoxing’s Revenues Climb; Net Income Still Negative

publication date: May 18, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Aoxing Pharmaceutical Company (中国奥星药业) reported its 2008 third quarter (ended March 31, 2009) results, saying revenues rose 85% to $1.6 million, largely because the company acquired Shijiazhuang Lerentang Pharmaceutical Company Ltd. (LRT) in 2008. LRT is a TCM drug company that, like China Aoxing, focuses on pain medications. China Aoxing said its operating loss in Q3 was $700,000 in Q3, about half the year-earlier period. More details...

Stock Symbol: (OTCBB: CAXG)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners